Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?
Burger
David M
DM
Siebers
Marijke C
MC
Hugen
Patricia W H
PW
Aarnoutse
Rob E
RE
Hekster
Yechiel A
YA
Koopmans
Peter P
PP
D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000378:metabolism*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D012737:Sex Factors
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir